Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.

Akio MiyasakaYuichi YoshidaAkiko SuzukiKei EndoKeisuke KakisakaTakayoshi OikawaTakaya AbeWataru ObaraTakayuki Matsumoto

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)

To eliminate HCV in HD facilities, it is necessary to promote HCV RNA testing for anti-HCV antibody-positive patients and to provide antiviral treatment for HCV RNA-positive patients. Additionally, collaboration among hepatologists and HD specialists are essential.

Keyphrases

hepatitis c virus
end stage renal disease
human immunodeficiency virus
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
smoking cessation
antiretroviral therapy
hiv infected